YOLFTbeta
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd

Daishin Balance No.6 Special Purpose Acquisition Co. Ltd

307750 · KQ · Healthcare / Drug Manufacturers - General

1,954.00KRW-35.00 (-1.76%)

Price History

Full chart

Market Stats

Previous Close1,989.00
Open2,000.00
Day Range1,950.00 – 2,055.00
52-Week Range1,700.00 – 6,000.00
Volume135.82K
Market Cap127.41B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta-0.26
50-Day Avg2,216.12
200-Day Avg3,040.87

About

KUKJEON Co.,Ltd operates as a chemical total solutions provider in South Korea. It provides various chemical-based products and services; and after-sales services, such as research and development, production, quality control, and DMF services. The company manufactures active pharmaceutical ingredients; and offers molecular design and technical support. It develops electronic materials, such as antistatic agents, monomers and polymers with low dielectric constant, and UV curing agents; low-resistance electrolyte, phosphine, silane, and boron compounds; semiconductor materials; and carbazole, boric acid, and fluorene intermediates. In addition, the company owns patents for its manufacturing methods. It serves pharmaceuticals, intermediate products, new drug synthesis, and related materials industries. The company was founded in 1972 and is headquartered in Anyang-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - General
  • CEOMr. Jongho Hong
  • Employees178
  • HeadquartersGeumgang Penterium IT Building, Anyang-si, South Korea, 14056, Korea
  • Websitehttps://www.kukjeon.co.kr

Leadership

  • Mr. Jongho HongChief Executive Officer · b. 1971

Financials

Income Statement

Currency: KRW2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue--80.62B85.35B103.71B122.00B136.47B131.04B
Growth (%)---+5.87%+21.51%+17.63%+11.86%-3.98%
Cost of Revenue--66.10B67.41B84.20B96.72B114.59B112.57B
Gross Profit--14.52B17.95B19.52B25.28B21.87B18.47B
Gross Margin--18.01%21.02%18.82%20.72%16.03%14.09%
Operating Expense--8.70B11.81B16.01B18.78B24.20B21.04B
Operating Income--66.29M5.82B6.13B3.51B6.50B-2.32B-2.58B
Operating Margin--7.22%7.19%3.38%5.33%-1.70%-1.97%
EBITDA----14.33B10.61B14.20B4.72B
EBITDA Margin----13.82%8.69%10.41%3.60%
Net Income--58.17M-3.32B4.04B8.95B4.82B1.74B-4.30B
Net Income Margin---4.11%4.73%8.63%3.95%1.27%-3.28%
R&D--830.11M2.65B3.98B4.82B4.68B3.63B
R&D as % of Total Revenue--1.03%3.11%3.84%3.95%3.43%2.77%
Interest Expense066.52M575.93M284.47M1.80B5.73B8.22B5.16B
Interest Expense % of Total Revenue--0.71%0.33%1.74%4.70%6.02%3.94%

Balance Sheet

Currency: KRW2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets--57.80B106.99B196.10B225.10B212.27B179.21B
Total Liabilities--25.57B23.84B103.77B127.65B114.85B83.33B
Total Equity--32.23B83.15B91.60B96.42B97.42B96.31B
Cash--9.78B19.10B21.55B10.99B13.74M7.69B
Net Debt-19.75B5.06B-37.44B67.22B17.59B37.48B

Cash Flow

Currency: KRW2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-57.21M-37.19M9.46B3.04B-6.02B-345.45M10.04B10.61B
Investing Cash Flow-27.00B-1.00B--32.58B-76.63B-24.31B42.80B-
Financing Cash Flow---38.86B85.10B14.11B-17.00B-
Capital Expenditure002.52B10.41B23.28B38.02B11.49B3.18B
Free Cash Flow--6.94B-7.38B-29.79B-38.37B-1.45B7.42B
Dividends Paid---490.69M490.69M0490.69M490.69M
FCF to OCF--73.40%-242.45%494.85%11105.76%-14.48%69.99%
Dividend Paid to FCF----6.65%-1.65%0.00%-33.77%6.61%

Earnings

Report DateDec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------------------------
EPS Actual-3.33-1.65-1.29-1.39-1.94-1.75-5.7025.5627.9243.2913.859.3228.3523.36-28.37159.0045.00-34.18-26.1963.8024.119.43-0.98-35.1518.03-2.40-57.81-47.91-52.2819.03
Surprise------------------------------
Timing------------------------------

Key Statistics & Ratios

Market Cap127.41B
Enterprise Value128.95B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.95
Price / Book1.08
Revenue (TTM)134.57B
Gross Profit (TTM)20.80B
EBITDA7.57B
Profit Margin-1.37%
Operating Margin3.70%
Return on Equity-1.94%
Return on Assets0.73%
Shares Outstanding53.99M
Shares Float25.69M
Beta-0.26
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20241×
10.00Dec 27, 2024
20231×
10.00Dec 27, 2023
20221×
10.00Dec 28, 2022
20211×
10.00Dec 29, 2021